Effectiveness of Adalimumab in Moderate to Severe HidrAdenitis SuppuRativa Patients - a Multi cOuNtry studY in Real Life Setting - HARMONY Study
Phase of Trial: Phase IV
Latest Information Update: 12 May 2017
At a glance
- Drugs Adalimumab (Primary)
- Indications Hidradenitis suppurativa
- Focus Therapeutic Use
- Acronyms Harmony
- Sponsors AbbVie
- 08 May 2017 Planned End Date changed from 1 Mar 2019 to 5 Jul 2019.
- 08 May 2017 Planned primary completion date changed from 1 Mar 2019 to 5 Jul 2019.
- 03 Feb 2017 Planned number of patients changed from 400 to 350.